CU20160069A7 - Sistema multiparticulado para administrar drogas - Google Patents

Sistema multiparticulado para administrar drogas

Info

Publication number
CU20160069A7
CU20160069A7 CUP2016000069A CU20160069A CU20160069A7 CU 20160069 A7 CU20160069 A7 CU 20160069A7 CU P2016000069 A CUP2016000069 A CU P2016000069A CU 20160069 A CU20160069 A CU 20160069A CU 20160069 A7 CU20160069 A7 CU 20160069A7
Authority
CU
Cuba
Prior art keywords
multiparticulated
drugs
manage
manage drugs
capsules
Prior art date
Application number
CUP2016000069A
Other languages
English (en)
Inventor
González Roberto Carlos Bravo
Felipe José Oliveira Varum
Kruif Jan Kendall De
Martin Kuentz
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of CU20160069A7 publication Critical patent/CU20160069A7/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sistema multiparticulado para administrar drogas. Proceso para prepararlo. Cápsulas que han sido rellenadas con él.
CUP2016000069A 2013-11-13 2016-05-13 Sistema multiparticulado para administrar drogas CU20160069A7 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13192657 2013-11-13
EP14157427 2014-03-03
PCT/EP2014/074501 WO2015071366A1 (en) 2013-11-13 2014-11-13 Multi-particulate drug delivery system

Publications (1)

Publication Number Publication Date
CU20160069A7 true CU20160069A7 (es) 2016-10-28

Family

ID=51900424

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2016000069A CU20160069A7 (es) 2013-11-13 2016-05-13 Sistema multiparticulado para administrar drogas

Country Status (19)

Country Link
US (1) US20160287521A1 (es)
EP (1) EP3068381B1 (es)
JP (2) JP2016537352A (es)
KR (1) KR20160085269A (es)
CN (1) CN105899197A (es)
AU (1) AU2014350208B2 (es)
CA (1) CA2930277A1 (es)
CL (1) CL2016001148A1 (es)
CR (1) CR20160263A (es)
CU (1) CU20160069A7 (es)
EA (1) EA201600387A1 (es)
HK (1) HK1224219A1 (es)
MD (1) MD20160061A2 (es)
MX (1) MX2016006275A (es)
NZ (1) NZ720512A (es)
PE (1) PE20160850A1 (es)
PH (1) PH12016500847A1 (es)
TN (1) TN2016000160A1 (es)
WO (1) WO2015071366A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019072877A1 (en) 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
US12371683B2 (en) 2018-07-25 2025-07-29 Alteogen Inc. Hyaluronidase variants and pharmaceutical composition comprising the same
KR102154565B1 (ko) * 2018-11-13 2020-09-10 한국화학연구원 천연 오일을 함유하는 미세캡슐 및 이의 제조방법
CN120053667A (zh) 2019-03-25 2025-05-30 阿特根公司 用于皮下注射的包含人透明质酸酶ph20变体和药物的药物组合物
CN111388759B (zh) * 2020-04-28 2021-09-07 四川大学 一种骨水泥复合材料及其制备方法
EP4194551A4 (en) 2020-08-07 2024-08-28 Alteogen, Inc. PROCESS FOR PRODUCING RECOMBINANT HYALURONIDASE
JPWO2024101250A1 (es) * 2022-11-11 2024-05-16
KR102847026B1 (ko) * 2023-08-25 2025-08-18 에바바이오 주식회사 프릴링 방법을 적용하여 제조한 다중소포성 리포좀의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657653B2 (ja) * 1985-08-23 1994-08-03 藤沢薬品工業株式会社 油性懸濁型直腸注入剤
DK0531497T3 (da) * 1991-04-02 1998-03-23 Biotech Australia Pty Ltd Orale indgivelsessystemer til mikropartikler
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
FR2754177B1 (fr) * 1996-10-07 1999-08-06 Sanofi Sa Microspheres pharmaceutiques d'acide valproique pour administration orale
YU86001A (sh) * 1999-06-07 2004-07-15 Altana Pharma Ag. Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP4046313B2 (ja) * 2001-01-12 2008-02-13 株式会社資生堂 油中水型乳化組成物およびこれを用いた乳化化粧料
WO2007076295A2 (en) * 2005-12-16 2007-07-05 University Of Kansas Nanoclusters for delivery of therapeutics
US7993749B2 (en) * 2005-12-16 2011-08-09 University Of Kansas Nanoparticles comprising a nanoparticle template and a polymer shell having an amide side chain, and method of making thereof
PT103476B (pt) * 2006-05-10 2008-09-19 Univ De Coimbra Processo de produção e isolamento de micro- e nanopartículas poliméricas contendo macromoléculas de natureza hidrofílica e termolábil
US9157054B2 (en) * 2007-11-14 2015-10-13 The University Of Queensland Device and method for preparing microparticles
EP2111854A1 (en) 2008-04-22 2009-10-28 Lek Pharmaceuticals D.D. Self-microemulsifying systems incorporated into liquid core microcapsules

Also Published As

Publication number Publication date
AU2014350208A1 (en) 2016-06-16
TN2016000160A1 (en) 2017-10-06
CR20160263A (es) 2017-04-05
JP2016537352A (ja) 2016-12-01
KR20160085269A (ko) 2016-07-15
EP3068381B1 (en) 2019-09-11
WO2015071366A1 (en) 2015-05-21
PH12016500847A1 (en) 2016-06-20
MD20160061A2 (ro) 2016-10-31
JP2019112413A (ja) 2019-07-11
EA201600387A1 (ru) 2016-08-31
EP3068381A1 (en) 2016-09-21
US20160287521A1 (en) 2016-10-06
CA2930277A1 (en) 2015-05-21
AU2014350208B2 (en) 2017-09-07
CL2016001148A1 (es) 2016-11-25
PE20160850A1 (es) 2016-09-23
NZ720512A (en) 2018-01-26
HK1224219A1 (zh) 2017-08-18
CN105899197A (zh) 2016-08-24
MX2016006275A (es) 2017-01-05

Similar Documents

Publication Publication Date Title
CU20160069A7 (es) Sistema multiparticulado para administrar drogas
IL245390B (en) Infusion system for preventing mischanneling of multiple medicaments
BR112015020743A2 (pt) cápsula de dose individual e sistema.
DK3062849T3 (da) Medikamentadministrationsanordning
EP2968993A4 (en) MANIPULATION-SAFE PHARMACEUTICAL FORMULATIONS
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
PT3404106T (pt) Sistema de expressão para terapia genética seletiva
DK3099356T3 (da) Medikamentadministrationsanordning
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
BR112015026025A2 (pt) dispositivo para administração de medicamento
DK3380146T3 (da) Medikamentadministrationsanordning
CL2014000864S1 (es) Envase de medicamento
CL2014000866S1 (es) Envase de medicamento
DK3357522T3 (da) Coatet medicinsk genstand til lægemiddelsfrigivelse
ZA201507576B (en) Pharmaceutical combination drug
BR112016011995A2 (pt) medicamentos inaláveis
DK3041546T3 (da) Indretning til en lægemiddeladministrationsanordning
DK2964193T3 (da) Lægemidler til oral indgivelse
PL2968351T3 (pl) Preparaty dawkowania modulatora receptora opioidowego
IL248962A0 (en) Device and method for administering drugs to the brain
IL245705A0 (en) Pharmaceutical dosage forms
LT3046537T (lt) Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui
DK3099357T3 (da) Medikamentadministrationsanordning
HRP20171888T1 (hr) Farmaceutski pripravci
UA28330S (uk) Капсула для лікарського засобу